CENTAUR is an AI decision support tool that works with Optical Coherence Tomography (OCT) volumes. It looks at the 3D volume and is able to provide insights into the health of the macula by indicating signs of diseases such as Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME) – both chronic diseases that contribute significantly to the demand for eye care services worldwide.
What is Age Related Macular Degeneration (AMD)?
“Age-Related Macular Degeneration” (or AMD), is a degenerative eye disease affecting 5% of the population over 60. AMD is projected to affect 196 million people worldwide by 2020, and is characterized by abnormal changes in the macula – the central part of the retina that is extremely important for patients’ detailed vision. There are two main forms of AMD: the dry form and the more severe, sight threatening wet form. Early recognition of the disease is paramount to effective treatment. Once diagnosed, the disease is monitored with monthly scans which all currently need to be reviewed by an Eye specialist.
What is Diabetic Macular Edema (DME)?
Diabetes can also effect the central part of the retina known as the macula. Through blood vessel leakage, deposits known as exudates can form, and the blood vessels leak to result in swelling of the macula region. This can drastically reduce a patients’ central vision, and immediate treatment by an Eye specialist is usually required.